Rankings
▼
Calendar
NVCR Q3 2024 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q3 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$155M
+21.8% YoY
Gross Profit
$120M
77.2% margin
Operating Income
-$32M
-20.7% margin
Net Income
-$31M
-19.7% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
+3.2%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
-$307,000
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$861M
Stockholders' Equity
$361M
Cash & Equivalents
$185M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$155M
$127M
+21.8%
Gross Profit
$120M
$95M
+25.7%
Operating Income
-$32M
-$58M
+44.9%
Net Income
-$31M
-$49M
+38.2%
Geographic Segments
UNITED STATES
$98M
50%
International Markets
$52M
27%
GERMANY
$17M
9%
FRANCE
$15M
8%
JAPAN
$9M
4%
CHINA
$5M
2%
← FY 2024
All Quarters
Q4 2024 →